0.5 hours | ACCME, ANCC
Recent data indicate that more than 10 million Americans have chronic rhinosinusitis (CRS), an inflammatory disease that is associated with $50 to $60 billion in annual healthcare costs. With no optimal treatment, quality of life in patients with CRS is generally poor. Prior research has also shown that 11% to 15% of patients with CRS also have GERD or reflux, making this disease much more common in CRS patients than in the general population. Reflux affects sinusitis in these patients, making it nearly refractory to therapy, therefore making GERD an important topic to study in the setting of CRS.